SAGILITY INDIA
Back to All Ratios
|
SAGILITY INDIA Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Core EBITDA Growth(%) | 6.81 | 396.20 | - |
What is the latest Core EBITDA Growth ratio of SAGILITY INDIA ?
Year | Core EBITDA Growth |
---|---|
Mar2024 | 6.81 |
Mar2023 | 396.20 |
Mar2022 | - |
How is Core EBITDA Growth of SAGILITY INDIA Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2024 | 6.81 | -98.28 | |
Mar2023 | 396.2 | 0 | |
Mar2022 | 0 | - |
Other Financial Ratios of SAGILITY INDIA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of SAGILITY INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAGILITY INDIA | ₹18,420.9 Cr | 2.8% | -10.8% | NA | Stock Analytics | |
SYNGENE INTERNATIONAL | ₹26,710.8 Cr | 2.4% | 5.4% | -3.9% | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹8,373.5 Cr | 1.3% | -1.8% | -16.1% | Stock Analytics | |
JUST DIAL | ₹7,682.1 Cr | 2.5% | -1.9% | -4.1% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,413.0 Cr | 2.3% | 10.6% | -25% | Stock Analytics | |
AWFIS SPACE SOLUTIONS | ₹4,689.8 Cr | -2.4% | 7.4% | 69.5% | Stock Analytics |
SAGILITY INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAGILITY INDIA | 2.8% |
-10.8% |
|
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses